1: Rea Reyes RE, Cody KA, Wilson RE, Zetterberg H, Chin NA, Jonaitis EM, Bahr M, Mandel O, Wintlend M, Bendlin BB, Okonkwo OC, Clark LR, Zammit M, Asthana S, Christian BT, Betthauser TJ, Eisenmenger L, Langhough RE, Johnson SC. Visual read of [F-18]florquinitau PET that includes and extends beyond the mesial temporal lobe is associated with increased plasma pTau217 and cognitive decline in a cohort that is enriched with risk for Alzheimer's disease. Alzheimers Dement. 2025 Feb;21(2):e14406. doi: 10.1002/alz.14406. Epub 2024 Nov 19. PMID: 39560002; PMCID: PMC11848396.
2: Varlow C, Vasdev N. Evaluation of Tau Radiotracers in Chronic Traumatic Encephalopathy. J Nucl Med. 2023 Mar;64(3):460-465. doi: 10.2967/jnumed.122.264404. Epub 2022 Sep 15. PMID: 36109185; PMCID: PMC10071800.
3: Knight AC, Morrone CD, Varlow C, Yu WH, McQuade P, Vasdev N. Head-to-Head Comparison of Tau-PET Radioligands for Imaging TDP-43 in Post-Mortem ALS Brain. Mol Imaging Biol. 2023 Jun;25(3):513-527. doi: 10.1007/s11307-022-01779-1. Epub 2022 Oct 18. PMID: 36258099.
4: Salman Y, Gérard T, Huyghe L, Colmant L, Quenon L, Malotaux V, Ivanoiu A, Lhommel R, Dricot L, Hanseeuw BJ; Alzheimer's Disease Neuroimaging Initiative. Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease. Alzheimers Dement. 2024 Oct;20(10):7205-7219. doi: 10.1002/alz.14235. Epub 2024 Sep 10. PMID: 39254209; PMCID: PMC11485073.
5: Shuping JL, Matthews DC, Adamczuk K, Scott D, Rowe CC, Kreisl WC, Johnson SC, Lukic AS, Johnson KA, Rosa-Neto P, Andrews RD, Van Laere K, Cordes L, Ward L, Wilde CL, Barakos J, Purcell DD, Devanand DP, Stern Y, Luchsinger JA, Sur C, Price JC, Brickman AM, Klunk WE, Boxer AL, Mathotaarachchi SS, Lao PJ, Evelhoch JL. Development, initial validation, and application of a visual read method for [18F]MK-6240 tau PET. Alzheimers Dement (N Y). 2023 Feb 12;9(1):e12372. doi: 10.1002/trc2.12372. PMID: 36873926; PMCID: PMC9983143.